Total Enrollment in Phase I, II, and III for the Year 2024

Phase III dominates with 529,388 participants in 2024.

PhasesTotal Enrollment
PHASE3529388
PHASE2169108
PHASE168180
Loading chart...

In pursuit of knowledge

In the year 2024, the landscape of clinical trials saw a significant enrollment trend across different phases. Phase III trials led the pack with a staggering 529,388 participants, showcasing the highest level of engagement and interest. Following closely behind, Phase II trials attracted 169,108 participants, while Phase I trials had 68,180 participants. This data highlights the progression of research and development efforts, with Phase III trials taking the lead in advancing potential treatments and therapies. The numbers speak volumes about the evolving dynamics of clinical research, with each phase playing a crucial role in the journey towards groundbreaking medical advancements.

00

Date published
20 Jun 2024